This is a preview of subscription content, log in via an institution to check access.
Notes
The study was funded by PregLem SA.
Reference
Geale K, et al. Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis. ClinicoEconomics and Outcomes Research : 1 Nov 2017. Available from: URL: https://doi.org/10.2147/CEOR.S143557
Rights and permissions
About this article
Cite this article
Ulipristal a cost-effective option for UFs. PharmacoEcon Outcomes News 791, 31 (2017). https://doi.org/10.1007/s40274-017-4515-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4515-5